Drug Type Immune cell therapy |
Synonyms ALV106 |
Target |
Mechanism CD4 agonists(T-cell surface antigen CD4 agonists), CD8 stimulants(Cluster of differentiation 8 stimulants) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Viral respiratory infection | Discovery | - | - |